# AMPICILLIN AND SULBACTAM
> **ANDA090340** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2010-09-20
## Drug
- **FDA Application Number:** ANDA090340
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPICILLIN AND SULBACTAM
- **Generic name:** AMPICILLIN SODIUM AND SULBACTAM SODIUM
- **Active ingredients:** AMPICILLIN SODIUM; SULBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** EUGIA PHARMA SPECLTS
- **Manufacturer:** Eugia US LLC
- **First approval:** 2010-09-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090340)
---
*MORVS · CC0 1.0*